Antivenom for European Vipera species envenoming

References

• Chippaux JP. Epidemiology of snakebites in Europe: a systematic review of the literature. Toxicon. 2012;59:86–99.
   PubMed Web of Science ®Google Scholar
• Speybroeck J, Beukema W, Bok B, et al. Field Guide to the Amphibians & Reptiles of Britain and Europe. London: Bloomsbury Publishing; 2016.
   Google Scholar
• Tekin R, Sula B, Cakir G, et al. Comparison of snakebite cases in children and adults. Eur Rev Med Pharmacol Sci. 2015;19:2711–2716.
   PubMed Web of Science ®Google Scholar
• Reid HA. Adder bites in Britain. BMJ. 1976;2:153–156.
   PubMed Web of Science ®Google Scholar
• Warrell DA. Treatment of bites by adders and exotic venomous snakes. BMJ. 2005;331:1244–1247.
   PubMed Web of Science ®Google Scholar
• Boels D, Hamel JF, Bretaudeau Deguigne M, et al. European viper envenomings: assessment of Viperfav and other symptomatic treatments. Clin Toxicol. 2012;50:189–196.
   PubMed Web of Science ®Google Scholar
• Lonati D, Giampreti A, Vecchio S, et al. Antivenom availability and clinical response to treatment in viper envenomation in Italy: a 3 years preliminary experience [abstract]. Clin Toxicol. 2016;54:512.
   Google Scholar
• Petite J. Viper bites: treat or ignore? Review of a series of 99 patients bitten by Vipera aspis in an alpine Swiss area. Swiss Med Wkly. 2005;135:618–625.
   PubMed Web of Science ®Google Scholar
• de Haro L, Lang J, Bedry R, et al. Snake bite by European vipers. A multicenter study of tolerance to Viperfav, a new intravenous antivenom. Ann Fr Anesth Reanim.1998;17:681–687.
   PubMed Web of Science ®Google Scholar
• Coulson JM, Cooper G, Krishna C, et al. Snakebite enquiries to the UK National Poisons Information Service: 2004–2010. Emerg Med J. 2013;30:932–934.
   PubMed Web of Science ®Google Scholar
• Persson H. Envenoming by European vipers antivenom treatment-influence on morbidity. Prz Lek. 2001;58:223–225.
   PubMedGoogle Scholar
• de Haro L, Glaizal M, Tichadou L, et al. Asp Viper (Vipera aspis) envenomation: experience of the Marseille Poison Centre from 1996 to 2008. Toxins (Basel). 2009;1:100–112.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Venomous snakes distribution and species risk categories. Geneva: WHO; 2016.
   Google Scholar
• Munich Poisons Information Centre. MAVIN. List of Antivenoms. Munich: Munich Poisons Information Centre; 2016.
   Google Scholar
• Toxinology Department WsCsH, Adelaide. Clinical Toxinology Resources. Adelaide: Toxinology Department, Women’s & Children’s Hospital; 2016.
   Google Scholar
• Chippaux JP, Goyffon M. Producers of antivenom sera. Toxicon. 1983;21:739–752.
   PubMed Web of Science ®Google Scholar
• Bolton FM, Casewell NR, Al-Abdulla I, et al. Production and assessment of ovine antisera for the manufacture of a veterinary adder antivenom. Vet Rec. 2014;174:406.
   PubMed Web of Science ®Google Scholar
• Theakston RD, Reid HA. Effectiveness of Zagreb antivenom against envenoming by the adder, Vipera berus. Lancet. 1976;2:121–123.
   PubMed Web of Science ®Google Scholar
• Casewell NR, Al-Abdulla I, Smith D, et al. Immunological cross-reactivity and neutralisation of European viper venoms with the monospecific Vipera berus antivenom ViperaTAb. Toxins (Basel). 2014;6:2471–2482.
   PubMed Web of Science ®Google Scholar
• Pepin-Covatta S, Lutsch C, Lang J, et al. Preclinical assessment of immunoreactivity of a new purified equine F(ab')2 against European viper venom. J Pharmaceut Sci. 1998;87:221–225.
   PubMed Web of Science ®Google Scholar
• Karlson-Stiber C, Persson H, Heath A, et al. First clinical experiences with specific sheep Fab fragments in snake bite. Report of a multicentre study of Vipera berus envenoming. J Intern Med. 1997;241:53–58.
   PubMed Web of Science ®Google Scholar
• de Haro L, Robbe-Vincent A, Saliou B, et al. Unusual neurotoxic envenomations by Vipera aspis aspis snakes in France. Hum Exp Toxicol. 2002;21:137–145.
   PubMed Web of Science ®Google Scholar
• Schroth M, Jungert J, Schreiber M, et al. Life-threatening snakebites by Vipera berus. Intensive Care Med. 2003;29:1615.
   PubMed Web of Science ®Google Scholar
• de Giacomo M, Cavaliere F, Gaspari R, et al. Coagulation dysfunction in Vipera aspis envenomation: do we need more data to encourage antivenom treatment? [abstract]. J Toxicol Clin Toxicol. 2003;41:519.
   Google Scholar
• Gronlund J, Vuori A, Nieminen S. Adder bites. A report of 68 cases. Scand J Surg. 2003;92:171–174.
   PubMedGoogle Scholar
• Lein S, Ringstad LG, Aakvik R, et al. Snake bites in Norway: experience of the National Poisons Information Centre and presentation of three cases of Vipera berus bites [abstract]. J Toxicol Clin Toxicol. 2004;42:467–468.
   Google Scholar
• Bubalo P, Curic I, Fister K. Characteristics of venomous snakebites in Herzegovina. Croat Med J. 2004;45:50–53.
   PubMed Web of Science ®Google Scholar
• Ertem K, Esenkaya I, Kaygusuz MA, et al. Our clinical experience in the treatment of snakebites. Acta Orthop Traumatol Turc. 2005;39:54–58.
   PubMedGoogle Scholar
• Luksic B, Bradaric N, Prgomet S. Venomous snakebites in southern Croatia. Coll Antropol. 2006;30:191–197.
   PubMedGoogle Scholar
• Frangides CY, Koulouras V, Kouni SN, et al. Snake venom poisoning in Greece. Experiences with 147 cases. European Journal of Internal Medicine. 2006;17:24–27.
   PubMed Web of Science ®Google Scholar
• Karlson-Stiber C, Salmonson H, Persson H. A nationwide study of Vipera berus bites during one year-epidemiology and morbidity of 231 cases. Clin Toxicol. 2006;44:25–30.
   PubMed Web of Science ®Google Scholar
• Acikalin A, Gokel Y, Kuvandik G, et al. The efficacy of low-dose antivenom therapy on morbidity and mortality in snakebite cases. Am J Emerg Med. 2008;26:402–407.
   PubMed Web of Science ®Google Scholar
• Hoegberg LC, Jessen CL, Lambertsen K, et al. Life-threatening systemic toxicity and airway compromise from a common European adder bite to the tongue. Acta Anaesthesiol Scand. 2009;53:1361–1364.
   PubMed Web of Science ®Google Scholar
• Petrolini V, Bellini A, Arrica M, et al. Anaphylaxis to ovine Fab-fragments in a child envenomed by European viper [abstract]. J Toxicol Clin Toxicol. 2009;47:499.
   Google Scholar
• Curic I, Curic S, Bradaric I, et al. Snakebites in Mostar region, Bosnia and Herzegovina. Coll Antropol. 2009;33(Suppl 2):93–98.
   PubMedGoogle Scholar
• Cesaretli Y, Ozkan O. Snakebites in Turkey: epidemiological and clinical aspects between the years 1995 and 2004. J Venom Anim Toxins incl Trop Dis. 2010;16:579–586.
   Web of Science ®Google Scholar
• Marinov I, Atanasov VN, Stankova E, et al. Severe coagulopathy after Vipera ammodytes ammodytes snakebite in Bulgaria: a case report. Toxicon. 2010;56:1066–1069.
   PubMed Web of Science ®Google Scholar
• Magdalan J, Trocha M, Merwid-Lad A, et al. Vipera berus bites in the Region of Southwest Poland–a clinical analysis of 26 cases. Wilderness Environ Med. 2010;21:114–119.
   PubMed Web of Science ®Google Scholar
• Karlo R, Dzelalija B, Zupancic B, et al. Venomous snakebites in the Croatian North Dalmatia region. Wien Klin Wochenschr. 2011;123:732–737.
   PubMed Web of Science ®Google Scholar
• Garkowski A, Czupryna P, Zajkowska A, et al. Vipera berus bites in Eastern Poland–a retrospective analysis of 15 case studies. Ann Agric Environ Med. 2012;19:793–797.
   PubMed Web of Science ®Google Scholar
• Saz-Parkinson Z, del Pino Luengo M, Lopez-Cuadrado T, et al. Approach to the epidemiology of venomous bites in Spain. Toxicon. 2012;60:706–711.
   PubMed Web of Science ®Google Scholar
• Claudet I, Marechal C, Gurrera E, et al. Risk factors for high-grade envenomations after French viper bites in children. Pediatr Emerg Care. 2012;28:650–654.
   PubMed Web of Science ®Google Scholar
• Sarc L, Sega S, Zidar J. Neurotoxicity caused by Vipera ammodytes bite: a case report. J Toxicol Clin Toxicol. 2013;51:275.
   Google Scholar
• Lapatto-Reiniluoto O. Severity of Vipera berus bites in Finland [abstract]. J Toxicol Clin Toxicol. 2013;51:274–275.
   Google Scholar
• Lonati D, Giampreti A, Rossetto O, et al. Neurotoxicity of European viperids in Italy: Pavia Poison Control Centre case series 2001–2011. Clin Toxicol. 2014;52:269–276.
   PubMed Web of Science ®Google Scholar
• Marano M, Pisani M, Stoppa F, et al. Antitoxin use and pediatric intensive care for viper bites in Rome, Italy. Eur Rev Med Pharmacol Sci. 2014;18:485–492.
   PubMed Web of Science ®Google Scholar
• Valenta J, Stach Z, Stritesky M, et al. Common viper bites in the Czech Republic – epidemiological and clinical aspects during 15 year period (1999–2013). Prague Med Rep. 2014;115:120–127.
   PubMedGoogle Scholar
• Iliev YT, Tufkova SG, Zagorov MY, et al. Snake venom poisoning in the Plovdiv region from 2004 to 2012. Folia Med (Plovdiv). 2014;56:32–37.
   PubMedGoogle Scholar
• Honge BL, Hedegaard SK, Cederstrom S, et al. Hospital contacts after bite by the European adder (Vipera berus). Dan Med J. 2015;62:A5022.
   Web of Science ®Google Scholar
• Claudet I, Grouteau E, Cordier L, et al. Hyperglycemia is a risk factor for high-grade envenomations after European viper bites (Vipera spp.) in children. Clin Toxicol. 2016;54:34–39.
   PubMed Web of Science ®Google Scholar
• Jollivet V, Hamel JF, de Haro L, et al. European viper envenomation recorded by French poison control centers: a clinical assessment and management study. Toxicon. 2015;108:97–103.
   PubMed Web of Science ®Google Scholar
• Karabuva S, Vrkic I, Brizic I, et al. Venomous snakebites in children in Southern Croatia. Toxicon. 2016;112:8–15.
   PubMed Web of Science ®Google Scholar
• Guiavarch M, Medus M, Tichadou L, et al. Uneven efficacy of Viperfav(R) antivenom for the treatment of neurotoxic viper envenomations. Presse Med. 2011;40:654–656.
   PubMed Web of Science ®Google Scholar
• Martin Sierra MC. Ofidismo en Aragon. In: Intoxicaciones por mordeduras de ofidios venenosos (I Panel de expertos en España) IPE 2012/68, edAmate Blanco JMCE, P. Madrid: Agencia de Evaluación de Tecnologías Sanitarias (AETS); 2012. p. 57–67.
   Google Scholar
• Carvalho C, Carvalho L, Neves F. Mordedura de víbora, situação rara mas potencialmente grave. Acta Pediatr Port. 2012;43:125–127.
   Google Scholar
• Vico Andueza L, Martínez Sanchez L, Martínez Osorio J, et al. Poisonous snakebites: a five-year experience. An Pediatr. 2015;83:209–211.
   Google Scholar
• Brvar M, Kurtović T, Grenc D, et al. Vipera ammodytes bites treated with antivenom ViperaTAb: a case series with pharmacokinetic evaluation. Clin Toxicol. 2017;55:241–248.
   PubMed Web of Science ®Google Scholar
• Malina T, Krecsak L, Jelic D, et al. First clinical experiences about the neurotoxic envenomings inflicted by lowland populations of the Balkan adder, Vipera berus bosniensis. Neurotoxicology. 2011;32:68–74.
   PubMed Web of Science ®Google Scholar
• Karlson-Stiber C, Persson H. Antivenom treatment in Vipera berus envenoming-report of 30 cases. J Intern Med. 1994;235:57–61.
   PubMed Web of Science ®Google Scholar
• Stahel E, Wellauer R, Freyvogel TA. [Poisoning by domestic vipers (Vipera berus and Vipera aspis). A retrospective study of 113 patients]. Schweiz Med Wochenschr. 1985;115:890–896.
   PubMedGoogle Scholar
• Mallow D, Ludwig D, Nilson G. True vipers: natural history and toxinology of the Old World vipers. Malabar (FL): Krieger publishing Company; 2003.
   Google Scholar
• Lalloo DG, Theakston RD. Snake antivenoms. J Toxicol Clin Toxicol. 2003;41:277–290.
   PubMed Web of Science ®Google Scholar
• Warrell DA. Guidelines for the management of snake-bites. Delhi: WHO Regional Office for South-East Asia; 2010.
   Google Scholar
• Dart RC, Seifert SA, Carroll L, et al. Affinity-purified, mixed monospecific crotalid antivenom ovine Fab for the treatment of crotalid venom poisoning. Ann Emerg Med. 1997;30:33–39.
   PubMed Web of Science ®Google Scholar
• Bush SP, Ruha AM, Seifert SA, et al. Comparison of F(ab')2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trial. Clin Toxicol. 2015;53:37–45.
   PubMed Web of Science ®Google Scholar
• Gonzalez D. Clinical aspects of bites by viper in Spain. Toxicon. 1982;20:349–353.
   PubMed Web of Science ®Google Scholar
• Ferquel E, de Haro L, Jan V, et al. Reappraisal of Vipera aspis venom neurotoxicity. PLoS One. 2007;2:e1194.
   PubMed Web of Science ®Google Scholar
• Ursenbacher S, Schweiger S, Tomovic L, et al. Molecular phylogeography of the nose-horned viper (Vipera ammodytes, Linnaeus (1758)): evidence for high genetic diversity and multiple refugia in the Balkan Peninsula. Mol Phylogenet Evol. 2008;46:1116–1128.
   PubMed Web of Science ®Google Scholar
• Westerstrom A, Petrov B, Tzankov N. Envenoming following bites by the Balkan adder Vipera berus bosniensis – first documented case series from Bulgaria. Toxicon. 2010;56:1510–1515.
   PubMed Web of Science ®Google Scholar